Summary
"The research conducted in SYSTEM_US (ERC Advanced Grant #232816) has led
to the discovery of valuable biomarkers for the quality of red blood cells (RBCs)
in standard blood bank storage conditions. Using a combination of systems
biology and metabolomics, this discovery will lead to the development of novel
RBC storage technologies including additive solutions and diagnostics. These
technologies will become valuable assets in the form of intellectual property to
large transfusion medicine companies and will save thousands of lives over the
coming decades. This proposal covers the needs to fully define the market and
NPV of the developing technology, fully define the regulatory and clinical path of
product approval, file for patents to protect the intellectual property, conduct
necessary validation experiments, and continue to develop relations with
industry contacts."
to the discovery of valuable biomarkers for the quality of red blood cells (RBCs)
in standard blood bank storage conditions. Using a combination of systems
biology and metabolomics, this discovery will lead to the development of novel
RBC storage technologies including additive solutions and diagnostics. These
technologies will become valuable assets in the form of intellectual property to
large transfusion medicine companies and will save thousands of lives over the
coming decades. This proposal covers the needs to fully define the market and
NPV of the developing technology, fully define the regulatory and clinical path of
product approval, file for patents to protect the intellectual property, conduct
necessary validation experiments, and continue to develop relations with
industry contacts."
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/641093 |
| Start date: | 01-03-2015 |
| End date: | 31-08-2016 |
| Total budget - Public funding: | 150 000,00 Euro - 150 000,00 Euro |
Cordis data
Original description
"The research conducted in SYSTEM_US (ERC Advanced Grant #232816) has ledto the discovery of valuable biomarkers for the quality of red blood cells (RBCs)
in standard blood bank storage conditions. Using a combination of systems
biology and metabolomics, this discovery will lead to the development of novel
RBC storage technologies including additive solutions and diagnostics. These
technologies will become valuable assets in the form of intellectual property to
large transfusion medicine companies and will save thousands of lives over the
coming decades. This proposal covers the needs to fully define the market and
NPV of the developing technology, fully define the regulatory and clinical path of
product approval, file for patents to protect the intellectual property, conduct
necessary validation experiments, and continue to develop relations with
industry contacts."
Status
CLOSEDCall topic
ERC-PoC-2014Update Date
27-04-2024
Images
No images available.
Geographical location(s)
